news 
Injective (INJ) Consolidates Near $13 as EVM Upgrade Boosts Developer Interest
The INJ price has stabilized near $12.96, indicating a consolidation phase following the recent 7.6% recovery to $13.31. This development underscores the potential for increased developer adoption, fueled by the successful launch of Injective’s Ethernia Upgrade on July 31st.
A critical factor in the current market condition is the introduction of Ethereum Virtual Machine (EVM) compatibility, which has sparked a renewed interest from developers. The Ethernia Upgrade marks an essential milestone for Injective, granting users seamless integration with popular dApps and DeFi platforms built on Ethereum. This strategic move positions the protocol to capitalize on the broader Ethereum ecosystem’s value capture.
The price action reflects a market digesting the implications of this significant technical advancement while encountering resistance near $16.35. The RSI currently sits at 47.92, suggesting neither overbought nor oversold conditions. However, traders must closely monitor the $13.85 level, as a decisive break above this 20-day moving average could signify renewed bullish momentum for INJ.
Furthermore, Binance’s proactive support during the network upgrade ensures that Injective’s technical capabilities have been thoroughly tested and validated by one of the world’s leading cryptocurrency exchanges. This collaboration reinforces institutional confidence in the project, reinforcing its long-term potential.
As market sentiment is neutral, day traders may find opportunities within the $12.55-$13.22 range established during yesterday’s trading session. They can use INJ’s RSI readings to time entries and exits within this band.
Source: Blockchain.News
